Advances in immunotherapeutic research for glioma therapy

Volume: 265, Issue: 4, Pages: 741 - 756
Published: Dec 5, 2017
Abstract
Gliomas are primary malignancies of the brain. Tumors are staged based on malignancy, nuclear atypia, and infiltration of the surrounding brain parenchyma. Tumors are often diagnosed once patients become symptomatic, at which time the lesion is sizable. Glioblastoma (grade IV glioma) is highly aggressive and difficult to treat. Most tumors are diagnosed de novo. The gold standard of therapy, implemented over a decade ago, consists of...
Paper Details
Title
Advances in immunotherapeutic research for glioma therapy
Published Date
Dec 5, 2017
Volume
265
Issue
4
Pages
741 - 756
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.